The 19th European Meeting on Complement in Human Diseases (EMCHD 2024), held in Lübeck, Germany, from September 2-6, 2024, was a landmark event for the scientific complement community. This prestigious conference brought together leading researchers, clinicians, and industry experts to discuss the ... Read more
We are excited to announce that Svar was the first Contract Research Organization (CRO) in the Nordics to be certified for Olink Proteomics Services! This certification underscores our commitment to providing cutting-edge solutions and reinforces our position as an expert partner in biomarker ... Read more
Neuromyelitis optica spectrum disorder (NMOSD) is an inflammatory, demyelinating disease in the central nervous system. The main characteristics of NMOSD are recurrent episodes of optic neuritis or acute myelitis. The area postrema syndrome, characterized by episodes of intractable hiccups and ... Read more
In the rapidly advancing field of gene therapy, adeno-associated viruses (AAV)stand out as powerful tools with immense potential. These vectors offer a precise means of delivering genetic material. However, ensuring their effectiveness and safety requires careful consideration of immunogenicity. To ... Read more
